van der Linden Mark, Perniciaro Stephanie, Imöhl Matthias
Institute for Medical Microbiology, German National Reference Center for Streptococci, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Germany.
BMC Infect Dis. 2015 May 5;15:207. doi: 10.1186/s12879-015-0941-9.
This study presents an analysis of 1,491 serogroup 23 and 762 serogroup 15 isolates from invasive pneumococcal disease (IPD) in children and adults before and after the general recommendation for childhood pneumococcal conjugate vaccination in Germany in July 2006. Vaccination formulations used were PCV7 (from July 2006), PCV10 (from April 2009) and PCV13 (from December 2009, replacing PCV7).
The German National Reference Center for Streptococci (GNRCS) has conducted surveillance of IPD since 1992. Isolates were serotyped and tested for antibiotic susceptibility. Selected isolates were characterized using MLST.
In an analysis of 23,957 isolates from IPD in children and adults sent to the GNRCS between July 1992 and June 2014, we found a strongly significant increase of non-PCV13 serotypes in the late vaccination (PCV13) period (2010-2014). Among these, the proportions of serotypes 15A and 23B were the most strongly significantly increasing. After the recommendation for pneumococcal conjugate childhood vaccination in 2006 and the introduction of higher-valent vaccines in 2009, the proportion of 15A increased significantly from 0.5% in the early vaccination period (2007-2010) to 2.4% in the late vaccination period (2010-2014, p=3.14 x 10(-22)). The proportion of serotype 23B increased from 0.5% to 2.8% in the same period (p=1.55 x 10(-29)). Penicillin non-susceptibility levels of the serotype 15A (47.4%) and serotype 23B (46.5%) isolates were high, with MIC values ranging from 0.12-2 μg/ml (15A) and 0.12-0.5 μg/ml (23B). MLSTs of serotype 23B isolates grouped in two clonal complexes (CC): CC439, with sequence type (ST) 439 as the main representative and CC338 (linked to CC156), with ST1349 as most prevalent clone. Both CCs have been present over almost the whole surveillance period. All penicillin non-susceptible isolates occurred in CC338. Serotype 15A isolates appeared to be more diverse. Six CCs, one group of three STs and two singletons were found among 20 isolates. Most prevalent was CC63, with ST63 as most prominent representative (n=5). Most penicillin non-susceptible isolates were found among CC63 isolates.
The prevalence of non-PCV13 serotypes in Germany has increased significantly between July 2007 and June 2014, with 15A and 23B being the most strongly increasing serotypes of all. Both serotypes show a high proportion of penicillin non-susceptibility.
本研究分析了2006年7月德国普遍推荐儿童接种肺炎球菌结合疫苗前后,1491株23血清型和762株15血清型侵袭性肺炎球菌病(IPD)分离株,这些分离株来自儿童和成人。使用的疫苗制剂有PCV7(自2006年7月起)、PCV10(自2009年4月起)和PCV13(自2009年12月起,取代PCV7)。
德国国家链球菌参考中心(GNRCS)自1992年起对IPD进行监测。对分离株进行血清分型并检测抗生素敏感性。使用多位点序列分型(MLST)对选定的分离株进行特征分析。
在对1992年7月至2014年6月间送至GNRCS的23957株儿童和成人IPD分离株进行分析时,我们发现在后期接种(PCV13)阶段(2010 - 2014年)非PCV13血清型显著增加。其中,15A和23B血清型的比例增加最为显著。2006年推荐儿童接种肺炎球菌结合疫苗以及2009年引入更高价疫苗后,15A血清型的比例从早期接种阶段(2007 - 2010年)的0.5%显著增加至后期接种阶段(2010 - 2014年)的2.4%(p = 3.14×10⁻²²)。同期,23B血清型的比例从0.5%增加至2.8%(p = 1.55×10⁻²⁹)。15A血清型(47.4%)和23B血清型(46.5%)分离株的青霉素不敏感水平较高,MIC值范围为0.12 - 2μg/ml(15A)和0.12 - 0.5μg/ml(23B)。23B血清型分离株的MLST分为两个克隆复合体(CC):CC439,以序列型(ST)439为主要代表;CC338(与CC156相关),以ST1349为最常见克隆。这两个CC在几乎整个监测期间都存在。所有青霉素不敏感分离株均出现在CC338中。15A血清型分离株似乎更为多样。在20株分离株中发现了6个CC、一组3个ST和2个单倍型。最常见的是CC63,以ST63为最突出代表(n = 5)。大多数青霉素不敏感分离株在CC63分离株中被发现。
2007年7月至2014年6月间,德国非PCV13血清型的流行率显著增加,15A和23B是所有血清型中增加最为显著的。这两种血清型均显示出较高比例的青霉素不敏感性。